PURPOSE The incidence of cardiometabolic risk factors in breast cancer (BC) survivors has
not been well described. Thus, we compared risk of hypertension, diabetes, and …

PURPOSE To examine cardiovascular disease (CVD) and mortality risk in women with
breast cancer (BC) by cancer therapy received relative to women without BC. METHODS …

BACKGROUND Few studies have examined the relationship between cardiometabolic risk
factors linked to metabolic syndrome and mortality among women with breast cancer …

Background Cardiometabolic abnormalities are a leading cause of death among women,
including women with cancer. Methods This study examined the association between …

Importance There is increasing interest in the effect of cardiovascular disease on cancer
survivors. However, there are limited contemporary population-based data on the risk of …

Objectives This study evaluates the risk of cardiovascular disease (CVD) following breast
cancer, accounting for baseline CVD risk. Methods Within the EPIC-NL (Dutch part of the …

Background: Cardiovascular disease (CVD) is of increasing concern among breast cancer
survivors. However, the burden of this comorbidity in this group relative to the general …

Background There is growing evidence that breast cancer survivors have higher
cardiovascular disease (CVD) mortality relative to the general population. Information on …

Opinion statement Cardiovascular disease (CVD) and breast cancer cause substantial
morbidity and mortality in women and are major public health concerns in the USA. While …

Background Cardiovascular disease (CVD) is the leading cause of morbidity and mortality
among older postmenopausal women. The impact of postmenopausal breast cancer on …